A detailed history of Private Advisor Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Private Advisor Group, LLC holds 159,421 shares of ABT stock, worth $18.8 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
159,421
Previous 161,716 1.42%
Holding current value
$18.8 Million
Previous $16.8 Million 8.17%
% of portfolio
0.12%
Previous 0.11%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$100.07 - $118.13 $229,660 - $271,108
-2,295 Reduced 1.42%
159,421 $18.2 Million
Q2 2024

Aug 05, 2024

SELL
$100.73 - $112.44 $462,552 - $516,324
-4,592 Reduced 2.76%
161,716 $16.8 Million
Q1 2024

Apr 30, 2024

SELL
$109.52 - $120.96 $160,994 - $177,811
-1,470 Reduced 0.88%
166,308 $18.9 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $2.31 Million - $2.83 Million
25,629 Added 18.03%
167,778 $18.5 Million
Q3 2023

Nov 02, 2023

SELL
$95.53 - $114.62 $48,529 - $58,226
-508 Reduced 0.36%
142,149 $13.8 Million
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $314,232 - $350,120
-3,118 Reduced 2.14%
142,657 $15.6 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $99,087 - $116,632
-1,023 Reduced 0.7%
145,775 $14.8 Million
Q4 2022

Jan 18, 2023

SELL
$95.06 - $111.52 $572,356 - $671,461
-6,021 Reduced 3.94%
146,798 $0
Q3 2022

Oct 14, 2022

SELL
$96.76 - $112.03 $8.93 Million - $10.3 Million
-92,312 Reduced 37.66%
152,819 $14.8 Million
Q2 2022

Jul 13, 2022

SELL
$102.07 - $123.37 $3.34 Million - $4.03 Million
-32,705 Reduced 11.77%
245,131 $26.6 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $129,070 - $157,393
1,132 Added 0.41%
277,836 $32.9 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $11.9 Million - $14.5 Million
-102,796 Reduced 27.09%
276,704 $38.9 Million
Q3 2021

Oct 14, 2021

BUY
$116.66 - $129.06 $18.6 Million - $20.5 Million
159,206 Added 72.27%
379,500 $44.8 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $269,447 - $317,177
2,547 Added 1.17%
220,294 $25.5 Million
Q1 2021

Apr 22, 2021

BUY
$108.84 - $128.23 $1.3 Million - $1.54 Million
11,979 Added 5.82%
217,747 $26.1 Million
Q4 2020

Apr 01, 2021

BUY
$105.0 - $114.42 $4.27 Million - $4.66 Million
40,692 Added 24.65%
205,768 $22.5 Million
Q3 2020

Nov 02, 2020

SELL
$91.64 - $111.29 $456,458 - $554,335
-4,981 Reduced 2.93%
165,076 $17.3 Million
Q2 2020

Aug 17, 2020

BUY
$76.57 - $98.0 $1.03 Million - $1.32 Million
13,511 Added 8.63%
170,057 $15.5 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $257,938 - $377,177
4,106 Added 2.69%
156,546 $12.4 Million
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $1.11 Million - $1.24 Million
-14,173 Reduced 8.51%
152,440 $13.2 Million
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $1.32 Million - $1.43 Million
16,127 Added 10.72%
166,613 $13.9 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $538,874 - $628,490
-7,394 Reduced 4.68%
150,486 $12.7 Million
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $1.2 Million - $1.45 Million
18,079 Added 12.93%
157,880 $12.6 Million
Q4 2018

Feb 11, 2019

SELL
$65.56 - $74.27 $1.1 Million - $1.24 Million
-16,730 Reduced 10.69%
139,801 $10.1 Million
Q3 2018

Nov 01, 2018

BUY
$60.81 - $73.36 $1.27 Million - $1.53 Million
20,856 Added 15.37%
156,531 $11.5 Million
Q2 2018

Aug 09, 2018

BUY
$57.57 - $63.54 $3.86 Million - $4.26 Million
66,986 Added 97.52%
135,675 $8.28 Million
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $2.18 Million - $2.46 Million
-38,736 Reduced 36.06%
68,689 $4.12 Million
Q4 2017

Feb 07, 2018

SELL
$53.68 - $57.47 $2.85 Million - $3.05 Million
-53,066 Reduced 33.06%
107,425 $6.31 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $63,487 - $70,858
1,321 Added 0.83%
160,491 $8.77 Million
Q2 2017

Aug 10, 2017

BUY
N/A
159,170
159,170 $7.68 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.